FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lynne Rueter

Research Profile

Living Beings

Chemicals & Drugs

Concepts & Ideas

Disorders

Activities & Behaviors

Physiology

Maze Learning

Co-author Network

Publications

TOP 3
Jordan W Brown; Lynne E Rueter; Caroline A Whitehead; Ana M Basso; Min Zhang
Preclinical evaluation of non-imidazole histamine H(3) receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia.
Chang Z Zhu; A W Bannon; M W Decker; D Gauvin; G C Hsieh; C-H Lee; L G Lewis; Joe Mikusa; C D Mills; Lynne E Rueter; C Zhong; S K Joshi
Assessing carrageenan-induced locomotor activity impairment in rats: comparison with evoked endpoint of acute inflammatory pain.
Kathy L Kohlhaas; Robert S Bitner; Murali Gopalakrishnan; Lynne E Rueter
Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lynne Rueter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jordan W Brown; Lynne E Rueter; Caroline A Whitehead; Ana M Basso; Min Zhang
Preclinical evaluation of non-imidazole histamine H(3) receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2013;16(4):889-904.
2012: Chang Z Zhu; A W Bannon; M W Decker; D Gauvin; G C Hsieh; C-H Lee; L G Lewis; Joe Mikusa; C D Mills; Lynne E Rueter; C Zhong; S K Joshi
Assessing carrageenan-induced locomotor activity impairment in rats: comparison with evoked endpoint of acute inflammatory pain.
European journal of pain (London, England) 2012;16(6):816-26.
2012: Kathy L Kohlhaas; Robert S Bitner; Murali Gopalakrishnan; Lynne E Rueter
Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosis.
Psychopharmacology 2012;220(4):823-33.
2012: Robert A Lenz; Charles Locke; Eric G Mohler; Lynne E Rueter; Walid Abi-Saab; Jeffrey D Baker; Keith Wesnes; Mario Saltarelli
The scopolamine model as a pharmacodynamic marker in early drug development.
Psychopharmacology 2012;220(1):97-107.
2011: Chih-Liang Chin; Peter Curzon; Annette J Schwartz; Elizabeth M O'Connor; Lynne E Rueter; Gerard B Fox; Mark Day; Ana M Basso
Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia.
Synapse (New York, N.Y.) 2011;65(5):393-403.
2011: Eric G Mohler; Kaitlin E Browman; Victoria A Roderwald; Elizabeth A Cronin; Stella Markosyan; R Scott Bitner; Marina I Strakhova; Karla U Drescher; Wilfried Hornberger; Jeffrey J Rohde; Michael E Brune; Peer B Jacobson; Lynne E Rueter
Acute inhibition of 11beta-hydroxysteroid dehydrogenase type-1 improves memory in rodent models of cognition.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011;31(14):5406-13.
2011: Ana M Basso; Kelly B Gallagher; Joe Mikusa; Lynne E Rueter
Vogel conflict test: sex differences and pharmacological validation of the model.
Behavioural brain research 2011;218(1):174-83.
2011: Min Zhang; Michael Ballard; Ana M Basso; Natalie Bratcher; Kaitlin E Browman; Peter Curzon; Ryuichi Konno; Axel H Meyer; Lynne E Rueter
Behavioral characterization of a mutant mouse strain lacking D-amino acid oxidase activity.
Behavioural brain research 2011;217(1):81-7.
2010: Eric G Mohler; Stanley R Franklin; Lynne E Rueter; Gerard B Fox; Michael W Decker; Kaitlin E Browman
ABT-594 improves performance in the 5-choice serial reaction time task under conditions of increased difficulty, sub-chronic dosing, and in poorly-performing subjects.
Pharmacology, biochemistry, and behavior 2010;95(2):146-57.
2010: Nathan R Rustay; Elizabeth A Cronin; Peter Curzon; Stella Markosyan; Robert S Bitner; Teresa A Ellis; Jeffrey F Waring; Michael W Decker; Lynne E Rueter; Kaitlin E Browman
Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's disease.
Brain research 2010;1311():136-47.
2010: Richard J Radek; Kathy L Kohlhaas; Lynne E Rueter; Eric G Mohler
Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists.
Current pharmaceutical design 2010;16(3):309-22.
2009: Ana M Basso; Natalie A Bratcher; Richard R Harris; Michael F Jarvis; Michael W Decker; Lynne E Rueter
Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders.
Behavioural brain research 2009;198(1):83-90.
2007: Jianguo Ji; William H Bunnelle; David J Anderson; Connie R Faltynek; Tino Dyhring; Philip K Ahring; Lynne E Rueter; Peter Curzon; Michael J Buckley; Kennan Marsh; Anita J Kempf-Grote; Michael D Meyer
A-366833: a novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane alpha4beta2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal models.
Biochemical pharmacology 2007;74(8):1253-62.
2007: Min Zhang; Michael Ballard; Liliane Unger; Andreas Haupt; Gerhard Gross; Michael W Decker; Karla U Drescher; Lynne E Rueter
Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine.
Behavioural brain research 2007;182(1):1-11.
2007: Michael Ballard; Ana M Basso; Kelly B Gallagher; Kaitlin E Browman; Gerard B Fox; Karla U Drescher; Gerhard Gross; Michael W Decker; Lynne E Rueter; Min Zhang
The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment.
Psychopharmacology 2007;190(1):1-11.
2006: Jennifer M Frost; William H Bunnelle; Karin R Tietje; David J Anderson; Lynne E Rueter; Peter Curzon; Carol S Surowy; Jianguo Ji; Jerome F Daanen; Kathy L Kohlhaas; Michael J Buckley; Rodger F Henry; Tino Dyhring; Philip K Ahring; Michael D Meyer
Synthesis and structure-activity relationships of 3,8-diazabicyclo[4.2.0]octane ligands, potent nicotinic acetylcholine receptor agonists.
Journal of medicinal chemistry 2006;49(26):7843-53.
2006: Ana M Basso; Natalie A Bratcher; Kelly B Gallagher; Marlon D Cowart; Chen Zhao; Minghua Sun; Timothy A Esbenshade; Michael E Brune; Gerard B Fox; Martin Schmidt; Christine A Collins; Andrew J Souers; Rajesh R Iyengar; Anil Vasudevan; Philip R Kym; Arthur A Hancock; Lynne E Rueter
Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxiety.
European journal of pharmacology 2006;540(1-3):115-20.
2006: Min Zhang; Michael Ballard; Kathy L Kohlhaas; Kaitlin E Browman; Ana-Lucia Jongen-Rêlo; Liliane Unger; Gerard B Fox; Gerhard Gross; Michael W Decker; Karla U Drescher; Lynne E Rueter
Effect of dopamine D3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(7):1382-92.
2006: Lynne E Rueter; Diana L Donnelly-Roberts; Peter Curzon; Clark A Briggs; David J Anderson; Robert S Bitner
A-85380: a pharmacological probe for the preclinical and clinical investigation of the alphabeta neuronal nicotinic acetylcholine receptor.
CNS drug reviews 2006;12(2):100-12.
2005: Ana M Basso; Kelly B Gallagher; Natalie A Bratcher; Jorge D Brioni; Robert B Moreland; Gin C Hsieh; Karla U Drescher; Gerard B Fox; Michael W Decker; Lynne E Rueter
Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(7):1257-68.
2005: Min Zhang; Michael Ballard; Liping Pan; Stanley Roberts; Ramin Faghih; Marlon D Cowart; Timothy A Esbenshade; Gerard B Fox; Michael W Decker; Arthur A Hancock; Lynne E Rueter
Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs.
Brain research 2005;1045(1-2):142-9.
2005: Gerard B Fox; Timothy A Esbenshade; Jia Bao Pan; Kaitlin E Browman; Min Zhang; Michael Ballard; Richard J Radek; Holly M Miner; Robert S Bitner; Kathleen M Krueger; Betty B Yao; Ramin Faghih; Lynne E Rueter; Victoria A Komater; Karla U Drescher; Michael J Buckley; James P Sullivan; Marlon D Cowart; Michael W Decker; Arthur A Hancock
Selective H3 receptor (H3R) blockade: broad efficacy in cognition and schizophrenia.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2005;54 Suppl 1():S23-4.
2005: Gerard B Fox; Timothy A Esbenshade; Jia Bao Pan; Richard J Radek; Kathleen M Krueger; Betty B Yao; Kaitlin E Browman; Michael J Buckley; Michael Ballard; Victoria A Komater; Holly M Miner; Min Zhang; Ramin Faghih; Lynne E Rueter; Robert S Bitner; Karla U Drescher; Jill M Wetter; Kennan Marsh; Martine Lemaire; Roger D Porsolt; Youssef L Bennani; James P Sullivan; Marlon D Cowart; Michael W Decker; Arthur A Hancock
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.
The Journal of pharmacology and experimental therapeutics 2005;313(1):176-90.
2005: Gilles Dube; Kathy L Kohlhaas; Lynne E Rueter; Carol S Surowy; Michael D Meyer; Clark A Briggs
Loss of functional neuronal nicotinic receptors in dorsal root ganglion neurons in a rat model of neuropathic pain.
Neuroscience letters 2005;376(1):29-34.
2004: Lynne E Rueter; Michael Ballard; Kelly B Gallagher; Ana M Basso; Peter Curzon; Kathy L Kohlhaas
Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia.
Psychopharmacology 2004;176(3-4):312-9.
2004: Kaitlin E Browman; Victoria A Komater; Peter Curzon; Lynne E Rueter; Arthur A Hancock; Michael W Decker; Gerard B Fox
Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan.
Behavioural brain research 2004;153(1):69-76.
2004: Lynne E Rueter; David J Anderson; Clark A Briggs; Diana L Donnelly-Roberts; Gary Gintant; Murali Gopalakrishnan; Nan-Horng Lin; Mark A Osinski; Glenn A Reinhart; Michael J Buckley; Ruth L Martin; Jeffrey S McDermott; Lee C Preusser; Terese R Seifert; Zhi Su; Bryan Cox; Michael W Decker; James P Sullivan
ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders.
CNS drug reviews 2004;10(2):167-82.
2004: Michael W Decker; Lynne E Rueter; Robert S Bitner
Nicotinic acetylcholine receptor agonists: a potential new class of analgesics.
Current topics in medicinal chemistry 2004;4(3):369-84.
2003: Lynne E Rueter; Kathy L Kohlhaas; Peter Curzon; Carol S Surowy; Michael D Meyer
Peripheral and central sites of action for A-85380 in the spinal nerve ligation model of neuropathic pain.
Pain 2003;103(3):269-76.
2000: Lynne E Rueter; Michael D Meyer; Michael W Decker
Spinal mechanisms underlying A-85380-induced effects on acute thermal pain.
Brain research 2000;872(1-2):93-101.
2000: Michael D Meyer; Michael W Decker; Lynne E Rueter; David J Anderson; Michael J Dart; K H Kim; James P Sullivan; Michael Williams
The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain.
European journal of pharmacology 2000;393(1-3):171-7.